LY2157299 Monohydrate (LY2157299) and Radiotherapy in Metastatic Breast Cancer
Status: TERMINATED
Study type: INTERVENTIONAL
Conditions: Metastatic Breast Cancer
Interventions: RADIATION: Radiation therapy|DRUG: Study Drug
Sponsor: Weill Medical College of Cornell University
Collaborators: University of California, Los Angeles